MediWound holder to sell 3,958 shares for $50K

MediWound Ltd. (MDWD) is the issuer of ordinary shares that Shmulik Hess intends to sell under Rule 144.

Rhea-AI Filing Summary

MediWound Ltd. (MDWD) is the issuer of ordinary shares that Shmulik Hess intends to sell under Rule 144. The notice covers a proposed sale of 3,958 ordinary shares, with an aggregate market value of $50,266.60, through Oppenheimer & Co. Inc. on Nasdaq. MediWound reports 12,835,148 ordinary shares outstanding as of the notice date context. The filing also notes that during the prior three months, Hess sold 1,865 ordinary shares for $24,245.00. The shares to be sold on August 27, 2026 were acquired upon exercise of employee stock options for cash.

Key Figures

Shares to be sold under Rule 144: 3,958 ordinary shares Aggregate market value of shares to be sold: $50,266.60 Shares outstanding: 12,835,148 ordinary shares +3 more

6 metrics

Shares to be sold under Rule 144 3,958 ordinary shares Planned sale by Shmulik Hess through Oppenheimer & Co. Inc.

Aggregate market value of shares to be sold $50,266.60 Value of 3,958 MediWound ordinary shares covered by the notice

Shares outstanding 12,835,148 ordinary shares MediWound ordinary shares outstanding in connection with the Rule 144 disclosure

Prior 3-month shares sold 1,865 ordinary shares Shares sold by Shmulik Hess on August 26, 2026

Proceeds from prior 3-month sales $24,245.00 Total consideration for 1,865 ordinary shares sold on August 26, 2026

Planned sale date 08/27/2026 Date of planned Rule 144 sale and option exercise-related acquisition

Key Terms

Rule 144, aggregate market value, ordinary shares, employee stock options, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"Ordinary Shares | Oppenheimer & Co. Inc. ... | 3958 | 50266.60 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

ordinary shares financial

"Ordinary Shares | Oppenheimer & Co. Inc. ... 3958 | 50266.60"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

employee stock options financial

"Shares acquired upon exercise of employee stock options"

Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.

Nasdaq market

"12835148 | 08/27/2026 | Nasdaq"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MediWound Ltd. (MDWD)'s Form 144 filing disclose?

It discloses that Shmulik Hess intends to sell 3,958 ordinary shares of MediWound Ltd. under Rule 144, with an aggregate market value of $50,266.60, through Oppenheimer & Co. Inc. on Nasdaq on August 27, 2026.

How many MediWound (MDWD) shares are planned to be sold under this Form 144?

The notice states that 3,958 ordinary shares of MediWound Ltd. are planned to be sold under Rule 144. These shares were acquired upon exercise of employee stock options for cash and are to be sold through Oppenheimer & Co. Inc..

What is the aggregate market value of the MDWD shares covered by this Form 144?

The filing reports an aggregate market value of $50,266.60 for the 3,958 ordinary shares of MediWound Ltd. to be sold under Rule 144. This figure appears in the securities information section of the notice.

How many MediWound (MDWD) shares are outstanding according to this notice?

The notice lists 12,835,148 ordinary shares outstanding for MediWound Ltd. This figure is presented as the number of shares outstanding in connection with the planned Rule 144 sale disclosure.

What prior sales by Shmulik Hess in MDWD shares does the Form 144 report?

The filing states that during the past three months, Shmulik Hess sold 1,865 ordinary shares of MediWound Ltd. on August 26, 2026 for a total of $24,245.00. These sales are reported in the "Securities Sold During The Past 3 Months" section.

How were the MediWound (MDWD) shares in this Form 144 acquired?

The notice describes the 3,958 ordinary shares to be sold as "Shares acquired upon exercise of employee stock options" with a "Cash payment upon exercise of stock options" on August 27, 2026, issued by MediWound Ltd..

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 08:45 AM EDT Accepted by SEC EDGAR 08/28/2026 - 06:36 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002085305
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MediWound Ltd.
SEC File Number	001-36349
Address of Issuer	42 Hayarkon Street Yavne ISRAEL 8122745
Phone	972779714100
Name of Person for Whose Account the Securities are To Be Sold	Shmulik Hess
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	3958	50266.60	12835148	08/27/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	08/27/2026	Shares acquired upon exercise of employee stock options	MediWound Ltd.			3958	08/27/2026	Cash payment upon exercise of stock options

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shmulik Hess 42 Hayarkon Street Yavne L3 8122745	Ordinary Shares	08/26/2026	1865	24245.00

144: Remarks and Signature

Remarks
Date of Notice	08/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Shmulik Hess By: /s/ Meirav Shemesh Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)